Secret drug pricing deals, a virtual AI cancer clinic, and other biotech news from The Readout
Manuel Balce Ceneta/AP
By Meghana Keshavan
May 7, 2026
Biotech Correspondent
Meghana Keshavan
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
A Duchenne therapy lawsuit, FDA Commissioner Marty Makary’s White House troubles, and other news from The Readout
Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news
A change to FDA clinical trial data review, Rocket sells its priority review voucher, and more biotech news from The Readout
A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates
